By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Intra-Cellular Therapies, Inc. 

3960 Broadway

New York  New York  10032  U.S.A.
Phone: 212-923-3344 Fax: 212-923-3388



Company News
Intra-Cellular Therapies (ITCI) Reports Second Quarter 2017 Financial Results And Provides Corporate Update 8/9/2017 12:50:51 PM
Intra-Cellular Therapies (ITCI) Presents At The 2017 International College Of Neuro-Psychopharmacology (CINP) Thematic Meeting On Treatment-Resistant Depression 7/20/2017 1:15:46 PM
Intra-Cellular Therapies (ITCI) Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/10/2017 10:41:24 AM
Intra-Cellular Therapies (ITCI) Presents Data Supporting The Potential For Potent And Rapid Antidepressant Activity With Lumateperone 5/8/2017 10:37:08 AM
Intra-Cellular Therapies (ITCI) Dropped To A New Low After the FDA Requests More Info On Schizophrenia Drug 5/1/2017 11:03:22 AM
Intra-Cellular Therapies's Future Up in the Air as Stock Plunges After Schizophrenia Study Fails 9/29/2016 6:51:15 AM
Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2015 Financial Results And Provides Corporate Update 2/25/2016 10:10:01 AM
Three Companies That Are Just as Great as Gilead (GILD) 2/4/2016 6:37:02 AM
Intra-Cellular Therapies To Present At The Leerink Partners’ 5th Annual Global Healthcare Conference 2/1/2016 8:14:13 AM
Intra-Cellular Therapies Reports Initiation Of Patient Enrollment For ITI-007 Phase 3 Clinical Trials In Bipolar Depression 12/23/2015 7:15:14 AM